Supplementation of scopoletin improves insulin sensitivity by attenuating the derangements of insulin signaling through AMPK

• Published in: Molecular and cellular biochemistry Vol. 453; no. 1-2; pp. 65 - 78
• Main Authors: Kalpana, Kalaivanan, Sathiya Priya, Chandrasekaran, Dipti, Nanda, Vidhya, Ramachandran, Anuradha, Carani Venkatraman
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.03.2019; Springer; Springer Nature B.V
• Subjects: 1-Phosphatidylinositol 3-kinase; Activated carbon; AKT protein; Antioxidants; Antioxidants (Nutrients); Biochemistry; Biomedical and Life Sciences; Carbonyl compounds; Carbonyls; Cardiology; Catalase; Coumarin; Diabetes mellitus; Diabetes mellitus (non-insulin dependent); Dietary supplements; EDTA; Fructose; Glucose; Glucose metabolism; Glutathione; Glutathione peroxidase; High fat diet; Inositol; Insulin; Insulin receptor substrate 1; Kinases; Life Sciences; Lipids; Medical Biochemistry; Membrane lipids; Metabolism; Oncology; Oxidative stress; Pancreas; Peroxidase; Phenolic compounds; Phenols; Phosphorylation; Plant lipids; Protein kinases; Proteins; Rats; Rodents; Signaling; Substrates; Superoxide dismutase; Superoxides; Type 2 diabetes; Insulin resistance; AMPK; AICAR; Scopoletin
• ISSN: 0300-8177; 1573-4919
• DOI: 10.1007/s11010-018-3432-7

Scopoletin (SPL), a phenolic coumarin, is reported to regulate glucose metabolism. This study is initiated to substantiate the action of SPL on the regulation of insulin signaling in insulin resistant RIN5f cells and high fat, high fructose diet (HFFD)-fed rat model. Adult male Sprague Dawley rats were fed HFFD for 45 days to induce type 2 diabetes and then treated or untreated with SPL for the next 45 days. The levels of glucose, insulin, lipid profile, oxidative stress markers along with insulin signaling and AMPK protein expressions were examined at the end of 90 days. SPL lowered the levels of plasma glucose, insulin, and lipids which were increased in HFFD-fed rats. HFFD intake suppressed the activities of antioxidant enzymes such as superoxide dismutase, catalase, and glutathione peroxidase; however, they were reversed by SPL supplementation, which reduced TBARS, lipid hydroperoxide, and protein carbonyl levels both in plasma and pancreas. SPL supplementation significantly activated insulin receptor substrate 1 (IRS1), phosphatidyl inositol 3-kinase (PI3K), and protein kinase B (Akt) phosphorylation which was suppressed in HFFD rats due to lipotoxicity. Moreover, SPL significantly activated AMPK and enhanced the association of IRS1-PI3K-Akt compared to the control group. The results revealed that SPL alleviated T2D induced by HFFD by escalating the antioxidant levels and through insulin signaling regulation. We conclude that SPL can improve insulin signaling through AMPK, thereby confirming the role of SPL as an AMPK activator.